Summary
PHILADELPHIA - It was a diet of bad news for NutriSystem Inc. yesterday.
Shares of the Horsham, Pa., company plunged 34 percent after the weight-loss firm lowered its third-quarter profit forecast, mainly on competition from GlaxoSmithKline's new diet pill, Alli. Analysts downgraded NutriSystem on the news, and even NutriSystem said it was surprised by the large hit to the stock, which closed down 33.6 percent, or $15.98, to $31.59.See the full content of this document
Extract
Alli Popularity Puts Nutrisystem On a Diet
After Glax...
See the full content of this document
Sponsored links
